UNCY - Unicycive Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UNCY is currently covered by 4 analysts with an average price target of $32. This is a potential upside of $22.99 (489.32%) from yesterday's end of day stock price of $5.43.

Unicycive Therapeutics's activity chart (see below) currently has 15 price targets and 45 ratings on display. The stock rating distribution of UNCY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.78% with an average time for these price targets to be met of 146.55 days.

Highest price target for UNCY is $63, Lowest price target is $13, average price target is $32.

Most recent stock forecast was given by ROBERT LEBOYER from NOBLE CAPITAL on 01-Jul-2026. First documented stock forecast 09-Aug-2021.

Currently out of the existing stock ratings of UNCY, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Feb-2024

$50

$44.27 (772.60%)

$6

7 days ago
(01-Jul-2026)

2/3 (66.67%)

$44.72 (846.97%)

87

Buy Since 17-Aug-2021

$13

$7.27 (126.88%)

$18

7 days ago
(01-Jul-2026)

2/7 (28.57%)

$7.72 (146.21%)

332

Buy Since 17-Aug-2021

$15

$8.37 (126.24%)

$21

3 months 2 days ago
(06-Apr-2026)

2/5 (40%)

$8.38 (126.59%)

332

Buy Since 09-Aug-2021

$63

$55.87 (783.59%)

7 months 26 days ago
(12-Nov-2025)

1/4 (25%)

$57.86 (1125.68%)

177

Buy Since 08-Jun-2022

$22

$14.87 (208.56%)

$7.5

8 months 9 days ago
(29-Oct-2025)

3/8 (37.5%)

$17.2 (358.33%)

44

Show more analysts

Please expand the browser size to see the chart

What is UNCY (Unicycive Therapeutics) average time for price targets to be met?

On average it took 146.55 days on average for the stock forecasts to be realized with a an average price target met ratio 35.78

Which analyst has the current highest performing score on UNCY (Unicycive Therapeutics) with a proven track record?

BRUCE JACKSON

Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?

Bruce Jackson works at BENCHMARK and has 4 price targets and 9 ratings on UNCY

Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?

Elemer Piros with highest potential upside - $57.27

Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?

Robert Leboyer with lowest potential downside - -$1.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?